139 related articles for article (PubMed ID: 16223608)
1. Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain.
Lee KO; Luu N; Kaneski CR; Schiffmann R; Brady RO; Murray GJ
Biochem Biophys Res Commun; 2005 Nov; 337(2):701-7. PubMed ID: 16223608
[TBL] [Abstract][Full Text] [Related]
2. HIV TAT variants differentially influence the production of glucocerebrosidase in Sf9 cells.
Vaags AK; Campbell TN; Choy FY
Genet Mol Res; 2005 Sep; 4(3):491-5. PubMed ID: 16342033
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of HIV-Tat protein transduction domain.
Yoon JS; Jung YT; Hong SK; Kim SH; Shin MC; Lee DG; Shin WS; Min WS; Paik SY
J Microbiol; 2004 Dec; 42(4):328-35. PubMed ID: 15650690
[TBL] [Abstract][Full Text] [Related]
5. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
Albarran B; To R; Stayton PS
Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
[TBL] [Abstract][Full Text] [Related]
6. TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death.
Soane L; Fiskum G
J Neurochem; 2005 Oct; 95(1):230-43. PubMed ID: 16181427
[TBL] [Abstract][Full Text] [Related]
7. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
[TBL] [Abstract][Full Text] [Related]
8. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
9. The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors.
Xia H; Mao Q; Davidson BL
Nat Biotechnol; 2001 Jul; 19(7):640-4. PubMed ID: 11433275
[TBL] [Abstract][Full Text] [Related]
10. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
[TBL] [Abstract][Full Text] [Related]
11. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC
Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612
[TBL] [Abstract][Full Text] [Related]
12. Transduction of Cu, Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into human chondrocytes.
Kim HA; Kim DW; Park J; Choi SY
Arthritis Res Ther; 2006; 8(4):R96. PubMed ID: 16792821
[TBL] [Abstract][Full Text] [Related]
13. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
15. Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity.
Sengoku T; Bondada V; Hassane D; Dubal S; Geddes JW
Exp Neurol; 2004 Jul; 188(1):161-70. PubMed ID: 15191812
[TBL] [Abstract][Full Text] [Related]
16. Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states.
Hakansson S; Caffrey M
Biochemistry; 2003 Aug; 42(30):8999-9006. PubMed ID: 12885232
[TBL] [Abstract][Full Text] [Related]
17. Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells.
Huang L; Farhood H; Serbina N; Teepe AG; Barsoum J
Biochem Biophys Res Commun; 1995 Dec; 217(3):761-8. PubMed ID: 8554596
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
Wadia JS; Dowdy SF
Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
[TBL] [Abstract][Full Text] [Related]
19. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model.
Lamghari M; Barrias CC; Sá Miranda C; Barbosa MA
Blood Cells Mol Dis; 2005; 35(3):348-54. PubMed ID: 16125984
[TBL] [Abstract][Full Text] [Related]
20. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
